Synthesis and kinase inhibitory activity of 3′-(S)-epi-K-252a

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 20, 2002, Pages 2829-2831

  Gingrich, Diane E ^a   Hudkins, Robert L ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; K 252A; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SUGAR ALCOHOL; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1;

ARTICLE; DIASTEREOISOMER; DRUG POTENCY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ALCOHOLS; CARBAZOLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PHOSPHOTRANSFERASES; RECEPTOR, TRKA; STEREOISOMERISM; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 0037152506     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00638-8     Document Type: Article

References (19)

1. Kase H., Iwahashi K., Matsuda Y. J. Antibiot. 39:1986;1059.
2. Kase H., Iwahasi K., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kanedo M. Biochem. Biophys. Res. Commun. 142:1987;436.
3. Omura S., Sasaki Y., Iwai Y., Takeshima H. J. Antibiot. 48:1995;535.
4. Sezaki M., Sasaki T., Nakazawa T., Takeda U., Iwata M., Watanabe T., Koyama M., Kai F., Shomura T., Kojima M. J. Antibiot. 38:1985;1437.
5. Ohmori K., Ishii H., Manabe H., Satoh H., Tamura T., Kase H. Arzneimittelforschung. 38:1988;809.
6. Knusel B., Hefti F. J. Neurochem. 59:1992;1987.
7. (a) Knusel B., Hefti F. J. Neurochem. 59:1992;1987 (b) Kaneko M., Saito Y., Saito H., Matsumoto T., Matsuda Y., Vaught J.L., Dionne C.A., Angeles T.S., Glicksman M.A., Neff N.T., Rotella D.P., Kauer J.C., Mallamo J.P., Hudkins R.L., Murakata C. J. Med. Chem. 40:1997;1863.
8. Wood J.L., Stoltz B.M., Dietrich H.-J., Pflum D.A., Petsch D.T. J. Am. Chem. Soc. 119:1997;9641.
9. Camoratto A.M., Jani J.P., Angeles T.S., Maroney A.C., Sanders C.Y., Murakata C., Neff N.T., Vaught J.L., Isaacs J.T., Dionne C.A. Int. J. Cancer 72:1997;673
10. Saporito M., Hudkins R., Maroney A. Progress in Medicinal Chemistry, Elsevier Science: Oxford. Vol. 40. 2002.
11. (a) Camoratto A.M., Jani J.P., Angeles T.S., Maroney A.C., Sanders C.Y., Murakata C., Neff N.T., Vaught J.L., Isaacs J.T., Dionne C.A. Int. J. Cancer. 72:1997;673 (b) Saporito M., Hudkins R., Maroney A. Progress in Medicinal Chemistry, Elsevier Science: Oxford. Vol. 40:2002;p 23 (c) Murakata C., Kaneko M., Gessner G., Angeles T.S., Ator M.A., O'Kane T.M., McKenna B.A.W., Thomas B.A., Mathiasen J.R., Saporito M.S., Bozyczko-Coyne D., Hudkins R.L. Bioorg. Med. Chem. Lett. 12:2002;147.
12. Murakata, C.; Sato, A.; Takahashi, M.; Kobayashi, E.; Morimoto, M.; Akinaga, S.; Hirata, T.; Mochida, K.; Kase, H.; Yamada, K.; Iwashashi, K. U.S. Patent 4,923,986, 1990; Chem. Abstr. 1988, 110, 75861e.
13. Zorbax RX C-8 column with an elution program of 10-100% acetonitrile/water with 0.1% TFA over 40 min at 1.6 mL/min.
14. Gingrich, D. E.; Hudkins R. H. WO 02/17914, 2002. Chem. Abstr. 2002, 136, 216643m and references cited within.
15. KC activity was assessed using the Millipore Multiscreen TCA "in plate" assay described. J. Biomol. Screening 1:1996;47
16. KC activity was assessed using the Millipore Multiscreen TCA "in plate" assay described in: Pitt, A. M.; Lee, C. J. Biomol. Screening 1996, 1, 47.
17. Ruggeri B.A., Miknyoczki S.J., Singh J., Hudkins R.L. Curr. Med. Chem. 6:1999;845.
18. (a) Ruggeri B.A., Miknyoczki S.J., Singh J., Hudkins R.L. Curr. Med. Chem. 6:1999;845 (b) Angeles T.S., Steffler C., Bartlett B.A., Hudkins R.L., Stephens R.M., Kaplan D.R., Dionne C.A. Anal. Biochem. 236:1996;49.
19. Maroney A.C., Finn J.P., Connors T.J., Durkin J.T., Angeles T., Gessner G., Xu Z., Meyer S.L., Savage M.J., Greene L.A., Scott R.W., Vaught J.L. J. Biol. Chem. 276:2001;25302.